Indian Vaccine Industry Examined in New Topical Daedal Research Report Now Available at MarketPublishers.com
15 Jan 2013 • by Natalie Aster
LONDON – India has established itself as the worldwide leading manufacturer and supplier of vaccines, providing over 28 different vaccines to consumers almost everywhere. With such renowned procurement agencies as UNICEF, Gates Foundation and GAVI being amid its key buyers, the country produces approximately two thirds of world vaccines.
The local vaccine production sector was worth slightly over USD 348 million in 2011. It is forecast to grow by USD 520 million by 2016, spurred by the expected demand boost from emerging economies.
New market research report “Indian Vaccine Industry: Trends & Opportunities (2012-2017)” drawn up by Daedal Research provides a comprehensive guide to the Indian vaccine industry. The study offers unique examination of the worldwide vaccine industry and Indian vaccine market. PEST analysis of the Indian vaccine industry, overview of factors igniting and clogging its growth, comprehensive discussion of industry trends can be bound in the report. Besides, the research study delves deep into the competitive pressure in the industry and limelights industry opportunities through 2017.
Indian Vaccine Industry: Trends & Opportunities (2012-2017)
Published: December, 2012
Price: US$ 800.00
More Cutting-Edge Indian Market Research Reports by Daedal Research Include:
- Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)
- Indian Patient Monitoring Market: Trends & Opportunities (2012-2017)
- Indian Recruitment Industry: Trends & Opportunities (2012-2017)
More insightful market research reports by the publisher are available at Daedal Research page.